AMH and polycystic ovary syndrome: Interestingly, we find the low ovarian response is less common in women with oligo/amenorrhea and the trend can be reversed when adjusted for AMH levels in women without PCOS, indicating that AMH may be a key confounding factor when MCL is used to predict AMH associated outcomes.